HS
HighVista Strategies Portfolio holdings
AUM
$272M
This Quarter Return
+13.28%
1 Year Return
+24.34%
3 Year Return
+176.43%
5 Year Return
+271.23%
10 Year Return
+682.63%
AUM
$168M
AUM Growth
+$168M
(-3.8%)
Cap. Flow
-$12.7M
Cap. Flow
% of AUM
-7.53%
Top 10 Holdings %
Top 10 Hldgs %
40.66%
Holding
139
New
26
Increased
28
Reduced
31
Closed
34
Top Buys
| 1 |
Axsome Therapeutics
AXSM
|
$2.95M |
| 2 |
SJI
South Jersey Industries, Inc.
SJI
|
$2.82M |
| 3 |
VRNA
Verona Pharma
VRNA
|
$1.79M |
| 4 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
$1.37M |
| 5 |
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
|
$1.26M |
Top Sells
| 1 |
CHNG
Change Healthcare Inc. Common Stock
CHNG
|
$4.46M |
| 2 |
Cytokinetics
CYTK
|
$3.54M |
| 3 |
CTXS
Citrix Systems Inc
CTXS
|
$3.26M |
| 4 |
NLSN
Nielsen Holdings plc
NLSN
|
$3.17M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
$2.81M |
Sector Composition
| 1 | Healthcare | 46.64% |
| 2 | Technology | 19.92% |
| 3 | Financials | 17.76% |
| 4 | Consumer Discretionary | 3.48% |
| 5 | Communication Services | 2.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Acadia Pharmaceuticals
ACAD
$4.38B
| $901K | 0.54% | 56,618 +3,300 | +6% | +$52.5K |
|
52
Ascendis Pharma
ASND
$11.8B
| $896K | 0.53% | 7,338 -2,442 | -25% | -$298K |
|
53
Keros Therapeutics
KROS
$618M
| $894K | 0.53% | +18,616 | New | +$894K |
|
54
United Therapeutics
UTHR
$13.8B
| $891K | 0.53% | 3,204 -662 | -17% | -$184K |
|
55
argenx
ARGX
$43.6B
| $884K | 0.52% | 2,333 +15 | +0.6% | +$5.68K |
|
56
Prothena Corp
PRTA
$441M
| $878K | 0.52% | +14,572 | New | +$878K |
|
57
Krystal Biotech
KRYS
$4.27B
| $876K | 0.52% | 11,058 +4,023 | +57% | +$319K |
|
58
Incyte
INCY
$16.5B
| $874K | 0.52% | 10,879 +5,831 | +116% | +$468K |
|
59
Microsoft
MSFT
$3.77T
| $844K | 0.5% | 3,520 -468 | -12% | -$112K |
|
60
Cullinan Oncology
CGEM
$445M
| $843K | 0.5% | 79,918 | – | – |
|
|
SGEN
61
DELISTED
Seagen Inc. Common Stock
SGEN
| $829K | 0.49% | 6,448 +770 | +14% | +$99K |
|
62
Legend Biotech
LEGN
$6.41B
| $809K | 0.48% | +16,212 | New | +$809K |
|
63
Pliant Therapeutics
PLRX
$101M
| $801K | 0.48% | +41,462 | New | +$801K |
|
64
Terns Pharmaceuticals
TERN
$609M
| $787K | 0.47% | 77,344 | – | – |
|
65
Biogen
BIIB
$19.4B
| $760K | 0.45% | +2,743 | New | +$760K |
|
66
Immunocore
IMCR
$1.62B
| $753K | 0.45% | 13,194 -3,394 | -20% | -$194K |
|
|
BLU
67
DELISTED
BELLUS Health Inc.
BLU
| $752K | 0.45% | 91,493 +14,649 | +19% | +$120K |
|
|
VERV
68
DELISTED
Verve Therapeutics
VERV
| $689K | 0.41% | +35,600 | New | +$689K |
|
69
GH Research
GHRS
$837M
| $638K | 0.38% | 65,597 +8,828 | +16% | +$85.8K |
|
|
AMRN
70
Amarin Corp
AMRN
$311M
| $606K | 0.36% | 500,680 | – | – |
|
71
Arvinas
ARVN
$568M
| $547K | 0.32% | 15,994 -2,262 | -12% | -$77.4K |
|
72
Generation Bio
GBIO
$40.4M
| $546K | 0.32% | 138,880 -110,114 | -44% | -$433K |
|
|
MRTX
73
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $530K | 0.31% | 11,703 +892 | +8% | +$40.4K |
|
74
Alphabet (Google) Class C
GOOG
$2.58T
| $530K | 0.31% | 5,970 -1,502 | -20% | -$133K |
|
75
TransDigm Group
TDG
$78.8B
| $508K | 0.3% | +807 | New | +$508K |
|